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Yersinia pestis is a highly pathogenic Gram-negative organism and the causative agent of bubonic and
pneumonic plague. Y. pestis is capable of causing major epidemics; thus, there is a need for vaccine targets and
a greater understanding of the role of these targets in pathogenesis. Two prime Y. pestis vaccine candidates are
the usher-chaperone fimbriae Psa and Caf. Herein we report that Y. pestis requires, in a nonredundant manner,
both PsaA and Caf1 to achieve its full pathogenic ability in both pneumonic and bubonic plague in C57BL/6J
mice. Deletion of psaA leads to a decrease in the organ bacterial burden and to a significant increase in the 50%
lethal dose (LD50) after subcutaneous infection. Deletion of caf1 also leads to a significant decrease in the
organ bacterial burden but more importantly leads to a significantly greater increase in the LD50 than was
observed for the psaA mutant strain after subcutaneous infection of C57BL/6J mice. Furthermore, the degree
of attenuation of the caf1 mutant strain is mouse background dependent, as the caf1 mutant strain was
attenuated to a lesser degree in BALB/cJ mice by the subcutaneous route than in C57BL/6J mice. This
observation that the degree of requirement for Caf1 is dependent on the mouse background indicates that the
virulence of Y. pestis is dependent on the genetic makeup of its host and provides further support for the
hypothesis that PsaA and Caf1 have different targets.
Yersinia pestis, the causative agent of both bubonic and
pneumonic plague (29), is a highly virulent organism that has
been responsible for three major pandemics in history, each
with a devastating morbidity rate (28). This medieval disease is
still pertinent today, as pockets of infected animals exist
throughout the world and human outbreaks still occur. After
transmission to a mammalian host from an infected flea, Y.
pestis is able to escape the host innate immune response and
colonize the proximal lymph node. If left untreated, the organ-
ism will proliferate in the lymph nodes, leading to swollen and
inflamed lymph nodes called buboes, a hallmark of bubonic
plague. From the lymph nodes, the organism is able to dissem-
inate and colonize the liver, spleen, and lungs. Colonization of
the lungs can develop into a secondary pneumonia and in some
instances leads to person-to-person transmission (primary
pneumonia) (28).
Early in infection, Y. pestis is thought to enter cells and
replicate intracellularly; however, as infection progresses, Y.
pestis is predominantly an extracellular organism (31). To sus-
tain itself extracellularly in the mammalian host, Y. pestis has
evolved factors that enable it to withstand the innate immune
system and inhibit phagocytosis (7–9, 39). Two of these anti-
phagocytic factors that inhibit the internalization of Y. pestis by
macrophages are surface-exposed capsular antigen fraction 1
(F1 or Caf1) and pH 6 antigen (Psa) fimbriae (14, 22). These
fimbriae appear to use different strategies to inhibit internal-
ization. Caf1 is thought to prevent adhesion to the epithelial
cells and thereby prevent internalization (25). In contrast, Psa
fimbriae promote adherence to cells but this interaction does
not lead to phagocytosis, possibly through interactions with an
unknown host receptor to block internalization (25).
Caf and Psa fimbriae have similar biogenesis mechanisms.
Both fimbriae use the chaperone/usher machinery to export
the subunits (Caf1 or PsaA) to the bacterial surface, where
they associate in a homopolymeric form (24, 46). In spite of
similar biogenesis mechanisms, both fimbriae produce unique
structures on the bacterial surface. By electron microscopy, the
PsaA fimbriae form individual strands, aggregates, or bundles
that protrude from the bacterial cell envelope (6, 24). In con-
trast, Caf1 forms an envelope or gel-like capsule (F1 antigen)
on the outer surface of the bacteria, which upon closer inspec-
tion consists of linear fibers that are loosely associated with the
bacteria (6, 34, 35, 46). Caf1 can also be detected in the su-
pernatants of cultures and in tissues of infected animals, indi-
cating that large quantities of the subunit are shed from the
bacterial surface (5, 11). The expression of both fimbrial oper-
ons is highly upregulated in the mammalian host and responds
to a temperature shift from 26°C to 37°C (21, 23, 26, 30).
As one of the most abundant surface-exposed epitopes dur-
ing mammalian infection, F1 is a prime vaccine candidate.
Immunization with different F1 constructs has been shown to
be protective against bubonic and pneumonic plague in mice
and is therefore included in several second-generation vaccines
(37). The low frequency of caf1-negative natural isolates and
infections in humans and animals suggests a selective pressure
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for F1/Caf in nature (27, 44). This, together with the increase
in caf1 gene expression during mammalian infection, implies
an important role for F1 in the mammalian phase of infection.
This is supported by several publications showing a require-
ment for F1 by Y. pestis for successful pathogenicity (2, 13, 17,
41, 43). However, recent work by independent groups has
shown that there is no increase in the 50% lethal dose (LD50)
with F1 mutant strains after infection via the subcutaneous
(s.c.) route in either BALB/cAnNCrl or Swiss-Webster mice
(10, 32, 36); this finding is supported by earlier studies that
investigated the role of F1 in other mammalian species (11, 17,
42, 45). The F1 antigen has been shown to be required for
successful transmission from the flea vector to the mammalian
host, as a caf1-negative strain was not as readily transmitted
from fleas to Swiss-Webster mice as the parental strain (36).
This finding suggests that flea-to-mammal transmission could
exert selective pressure for maintenance of the caf locus. Com-
bined, these conflicting data indicate that the exact require-
ment of F1 in the mammalian phase of infection remains to be
elucidated.
In the light of recent in vitro data that PsaA and F1 have
redundant (or partially redundant) functions (25), it is worth
revisiting the role of F1 in a mammalian infection. Thus, the
phenotypes of psaA and caf1 single mutants, as well as a
psa caf1 double mutant, in our mouse models of infection
were investigated. The results suggest that both fimbriae are
required for pathogenesis during bubonic and pneumonic in-
fections and that their functions are not completely redundant.
Finally, we also demonstrate that the degree of the contribu-
tion of F1 to Y. pestis pathogenesis is mouse background de-
pendent.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Wild-type Y. pestis CO92 (naturally
polymyxin B resistant) is a clinical isolate from a pneumonic infection provided
by the U.S. Army Medical Research Institute of Infectious Diseases, Fort De-
trick, MD (12). The psaA (YP16) mutant strain was constructed and described
previously (3). Strains were cultivated at 26°C on brain heart infusion (BHI;
Difco, Sparks, MD) plates for 48 h. Liquid cultures of CO92 were grown for 15 h
with aeration at 26°C in BHI or at 37°C in BHI supplemented with 2.5 mM
CaCl2, unless otherwise noted. When needed, antibiotics were used at the fol-
lowing concentrations: kanamycin, 50 g/ml; polymyxin B, 25 g/ml; ampicillin,
50 g/ml.
caf1 and psaA caf1 plasmid and mutant strain construction. A deletion of
the caf1 gene in wild-type CO92 and in the psaA mutant strain (YP16) was
generated using a modified form of  Red recombination as previously described
(3). In brief, the 500 bp upstream and the 500 bp downstream of caf1 were
independently amplified by PCR with primers caf1-5-501 (5-CAT CAC CAA
TTA TGG TTA CTT AAC CCC TTA-3) and caf1-5512-P4 (5-GGT CGA
CGG ATC CCC GGA ATA ATC CAT ATA GAT AAT AGA TAA AGG AGG
GCT-3) for the upstream fragment and caf1-33-P1 (5-GAA GCA GCT CCA
GCC TAC ACC ATA TAT TAC CTC TAT CGA ATA ATC CAA TCC
ACG-3) and caf1-31004 (5-CTC TTG CTC TCC TCA AGA GGG TC-3)
for the downstream region. The resulting products were gel purified and com-
bined with a kan cassette flanked by FRT sites (previously amplified from
plasmid pKD13 by PCR) in a second PCR amplification using primers caf1-5-
501 and caf1-31004. The resulting fragment then was used to generate the
caf1 (YP229) and psaA caf1 (YP292) mutant strains with the modified form
of  Red recombination as previously described (3).
To restore caf1 in the caf1 mutant strain in its native position, the entire open
reading frame of caf1 and the 500 to 800 bp flanking caf1 were amplified by PCR
using DNA purified from CO92 as the template and primers F-caf1comp-5-Sal
(5-GCG TCG ACG TGT ACG GTG AAG CCT TTG ATC-3) and
R-caf1comp3 5693Not (5-ATA AGA ATG CGG CCG CAG TTG CAT GGA
TGA TGG ATA CC-3). The PCR fragment was digested with SalI and NotI and
cloned into the same sites of suicide vector pSR47S (40). The resulting plasmid,
pGK511, was confirmed by sequencing. Plasmid pGK511 was conjugated into the
caf1 mutant strain, and recombination of caf1 into the native site was confirmed
by PCR. The resulting Kans caf1 strain was designated YP306.
Animal infections. All animal experiments were approved by either the Wash-
ington University Animal Studies Committee (protocol 20050189) or the Uni-
versity of North Carolina IACUC (protocol 2008-144). Five- to 7-week-old fe-
male C57BL/6J mice from The Jackson Laboratory (Bar Harbor, ME) were
maintained in the Washington University barrier facility with sterilized food and
water ad libitum. Five- to 7-week-old female BALB/cJ mice from The Jackson
Laboratory (Bar Harbor, ME) were maintained in the University of North
Carolina animal facility with food and water ad libitum. Before infection, all mice
were anesthetized with a mixture of ketamine HCl (100 mg/ml) and xylazine HCl
(20 mg/ml) mixed 1:1 and delivered at a dose of 0.5 ml/kg of body weight by
intraperitoneal (i.p.) injection. Mice were euthanized by i.p. injection of pento-
barbital (Nembutal) sodium at a dose of 0.5 mg/kg of body weight.
Virulence assays were performed as described previously (3). In brief, groups
of mice were infected for each time point examined with either wild-type strain
CO92 or a mutant by s.c. injection of 100 l (2  102 CFU) into the neck or
20 l intranasal (i.n.) inoculation (1  104 CFU). At various times after
inoculation, mice were euthanized and their lungs, spleens, and superficial cer-
vical lymph nodes were removed. The bacterial load of each organ was deter-
mined by plating dilutions of the macerated tissues onto BHI agar and reported
as the number of CFU per gram of tissue. Infections were repeated in at least two
independent experiments. To determine the LD50, four groups of 10 mice were
infected with serial 10-fold dilutions of the bacterial suspension (105 to 1 CFU
for s.c. inoculations). Mice were checked every 12 h for 7 days, and the LD50 was
calculated as previously described (33). For survival analysis, groups of 10 mice
were infected i.n. with 1  104 CFU. Mice were checked every 12 h for 7 days,
and the mean number of days to death (MDD) was determined.
Statistical analysis. Statistical analysis was performed using Prism software
from GraphPad Software, Inc. Statistical significance was determined using the
Mann-Whitney t test with a two-tailed nonparametric analysis. When comparing
data points with a large quantity of undetectable samples, a contingency analysis
was performed using the Fisher exact test. Statistical analysis of the survival
curves was determined using the log rank test.
RESULTS
Both PsaA and Caf1 are required for bubonic infection.
PsaA and Caf1 are members of the same protein family and
form fimbrial structures on the surface of Y. pestis. Deletion of
either type of fimbriae increases uptake of Y. pestis by human
respiratory tract epithelial cells in vitro, and this phenotype is
enhanced in a double mutant (25). We previously demon-
strated that a psaA mutant is defective for colonization in a
bubonic plague model (3), suggesting that F1 cannot com-
pletely compensate for the absence of PsaA during bubonic
infection. To further investigate the individual roles of PsaA
and Caf1 during bubonic infection, C57BL/6J mice were in-
fected with 200 CFU of Y. pestis strains with psaA, caf1, or
both genes (psaA caf1) deleted to determine the impact of
these deletions on the progression of infection.
At designated time points, cervical lymph nodes, spleens,
and lungs were harvested to determine the number of CFU/g
in these tissues. At 36 h postinfection, 108 CFU/g were recov-
ered from the cervical lymph nodes of the wild-type-infected
mice, whereas both the psaA and caf1 mutant strains
showed diminished colonization, with 106 to 107 CFU/g re-
covered (Fig. 1A). The psaA caf1 double mutant displayed
an even greater reduction in colonization of the lymph node.
The bacterial load in these mice was 3 logs lower than in
wild-type-infected tissues and 1 to 2 logs lower than in tissues
from mice infected with the single mutants. However, it should
be noted that a substantial number of the psaA caf1 double
mutant-infected mice (64%) did not have detectable bacteria
VOL. 79, 2011 Y. PESTIS CAPSULE AND MOUSE BACKGROUND 645
at that time. By 48 h postinfection, all of the mutants were still
significantly attenuated compared to the wild type. However,
while the wild-type and caf1 mutant bacteria proliferated in
the lymph nodes, neither the psaA nor the psaA caf1
mutant strain showed expansion of CFU at that time (Fig. 1A).
The bacterial loads in the single mutant- and double mutant-
infected mice were significantly lower than that in wild-type-
infected mice by 3 and 5 logs, respectively. At 72 h, the
number of CFU/g recovered from wild-type-infected mice re-
mained at about 109, whereas the psaA and caf1 mutant
strains proliferated after 48 h, also reaching 109 CFU/g. The
psaA caf1 double mutant strain also expanded, reaching
5  107 CFU/g. However, this level is nearly 2 logs lower
than that in the wild-type- and single mutant-infected mice.
To investigate the impact of the psaA and caf1 deletions on
dissemination, we enumerated the CFU/g in the spleens at 48
and 72 h and in the lungs at 72 h postinfection. After 48 h, we
were unable to recover organisms from most of the spleens
from any of the mutant-infected mice, whereas all of the wild-
type-infected mice were colonized (median bacterial load,
103 CFU/g) (Fig. 1B). By 72 h postinfection, the spleens from
mice infected with the single mutants were colonized, but at
significantly lower numbers than those of mice infected with
the wild type. In the case of the double mutant, only 36% of the
infected mice had colonized spleens in which the bacterial
numbers were significantly lower than the wild-type- or single
mutant-infected spleens (5 logs and 2 logs lower, respec-
tively) (Fig. 1B). All of the mutant strains were also deficient in
the ability to disseminate to the lungs. While all of the wild-
type-infected mice had bacteria in their lungs at 72 h (median,
104 CFU/g), only 43% of the mice infected with the psaA
mutant were colonized and no mice infected with the caf1 or
psaA caf1 mutant strain had detectable bacteria in their
lungs (Fig. 1C).
To confirm that the phenotypes observed in the experiments
described above were due to the deletion of the respective
genes, an independent kinetic study with the wild type, the
mutants, and the single mutants with a native copy of their
respective genes restored, was performed in the same manner
as the above-described experiments. Complementation of the
single mutants with a native copy of their respective genes
completely restored pathogenesis (psaA [3], caf1 [data not
shown]). These data indicate that the psaA, caf1, and psaA
caf1 mutant strains all have an attenuated ability to colonize
the lymph nodes and disseminate. Furthermore, the double
mutant is more attenuated than either single mutant, suggest-
ing that Y. pestis has nonredundant requirements for both
PsaA and Caf1 in bubonic plague in C57BL/6J mice.
Loss of PsaA and Caf1 result in an increase in the LD50 and
survival during bubonic plague. The significant delay in the
FIG. 1. Colonization and dissemination of psaA, caf1, and
psaA caf1 mutant Y. pestis strains in C57BL/6J mice during bubonic
plague. Mice were infected s.c. in the neck with 102 CFU of the
wild-type (wt, diamonds) or psaA (triangles), caf1 (squares), or
psaA caf1 (circles) mutant strain. Mice were sacrificed at 36, 48, and
72 h postinfection, and colonization of the superficial cervical lymph
nodes (A), spleen (B), and lungs (C) was determined. Each symbol
represents an individual animal. Black bars correspond to the median
number of CFU/g of tissue for each group. The dashed line indicates
the limit of detection. Asterisks in the graph indicate a significant
difference between the median number of CFU/g of tissue between the
psaA and caf1 groups, whereas asterisks in the table indicate a
significant difference between the median number of CFU/g of tissue
compared to either the wild-type or the psaA caf1 mutant strain (*,
P  0.05; **, P  0.01; ***, P  0.005; na, not applicable; ns, not
significant). The data represent three independent experiments. The
numbers of tissue samples harvested for the wild-type and psaA,
caf1, and psaA caf1 mutant strains, respectively, were 20, 7, 14,
and 14 at 36 h; 21, 7, 14, and 14 at 48 h; and 19, 7, 14, and 14 at 72 h.
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colonization and dissemination of the psaA and caf1 mu-
tants suggested that mutant-infected mice might survive longer
than wild-type-infected animals or a larger number of mutant
bacteria would be required for a lethal infection. To test this
hypothesis, C57BL/6J mice were infected with 10-fold dilutions
of the wild-type or the psaA, caf1, or psaA caf1 mutant
strain and monitored for disease progression every 12 h for 7
days. Mice were infected with doses ranging between 1 and 103
organisms of the wild-type and psaA mutant strains, and
doses ranging between 100 and 105 organisms of the caf1 and
psaA caf1 mutant strains. The LD50 of the wild-type strain
in C57BL/6J infected by the s.c. route was determined to be 1
CFU, which is consistent with previous reports (Fig. 2A) (3).
The LD50 of the psaA mutant strain was 400-fold higher than
that of the wild type, with 40%, 80%, and 90% of the mice
surviving doses of 1,000, 100, and 10 CFU, respectively (Fig.
2B). The caf1 mutant strain was more attenuated, and in fact,
we were unable to calculate an LD50 of this mutant, as 60% of
the mice infected with the highest dose (105 CFU) survived the
course of the infection. We also were unable to determine an
LD50 of the psaA caf1 mutant strain, as all but one mouse
survived all of the doses tested. Therefore, the LD50 was sig-
nificantly greater than 105 CFU, which is similar to the LD50 of
the caf1 mutant strain, and a significant increase over that of
both the wild-type and psaA mutant strains. This LD50 ex-
periment was repeated independently for all four strains, with
similar results (data not shown). Although we were unable to
calculate an LD50 of the caf1 or psaA caf1 mutant, the
data suggest that there may be a difference in virulence be-
tween the caf1 and psaA caf1 mutant strains. Whereas
20% of the mice infected with all of the doses of the caf1
mutant strain combined succumbed to the infection, only 3%
of the psaA caf1 mutant-infected mice succumbed.
Because it appeared that, in the LD50 experiment, the psaA
caf1 mutant strain was more attenuated than the caf1 mu-
tant strain, we sought to determine if there was any difference
in organ burden in these mice. At 7 days postinfection, a subset
of the surviving mice infected with 100 CFU (low dose) or 105
CFU (high dose) of the caf1 or the psaA caf1 mutant
strain from the two independent LD50 experiments (Fig. 2)
were sacrificed. The bacterial burdens recovered at 7 days
postinfection from the lymph nodes and spleens of mice given
the low and high doses of the caf1 mutant strain were signif-
icantly greater than those recovered from mice infected with
the equivalent infectious doses of the psaA caf1 mutant
strain (P  0.05 for the lymph nodes, P  0.005 for the spleen)
(data not shown). In the majority of the mice infected with the
low dose of either strain, we were unable to recover live or-
ganisms, especially in the lungs. However, at the high dose,
sufficient mice were colonized that a difference in bacterial
burden could be observed in the lungs of the caf1 and psaA
caf1 mutant strain-infected mice, as 78% and 36%, respec-
tively, of the mice had detectable levels of bacteria (P  0.05)
(data not shown). Overall, both the caf1 and psaA mutant
strains had a significantly attenuated ability to produce bu-
bonic plague in C57BL/6J mice, and deletion of both genes led
to an additional increase in attenuation.
Both PsaA and Caf1 are required for pneumonic infection.
While our data strongly suggest that both PsaA and F1 are
required for bubonic infection, several laboratories have re-
ported that F1 is not required for bubonic or pneumonic
plague in mice (10, 32, 36). We therefore set out to determine
FIG. 2. Survival and LD50 analysis in C57BL/6J mice infected with the wild-type and psaA, caf1, and psaA caf1 mutant strains of Y. pestis.
Groups of 10 mice were infected s.c. in the neck with serial 10-fold dilutions of the wild-type (A) or psaA (B), caf1 (C), or psaA caf1
(D) mutant strain. Shown is a representative experiment of two independent experiments.
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if these proteins impact pneumonic infection in our model.
Toward this end, mice were infected i.n. with the psaA, caf1,
and psaA caf1 mutant strains and colonization and dissem-
ination were compared to those in wild-type-infected animals.
At 12 h postinfection, all three mutant strains displayed a
modest but significant reduction (1 log) in bacterial counts in
the lungs compared to wild-type-infected mice and this de-
creased bacterial burden was constant in the lungs throughout
the course of the experiment (Fig. 3A). By 60 h postinfection,
there was a significant difference in bacterial counts between
the single mutants and the double mutant; the median bacte-
rial loads in the single mutant-infected mice were approxi-
mately 10-fold less than those in wild-type-infected animals,
compared to an approximately 100-fold difference for the dou-
ble mutant-infected animals. Dissemination of the mutant bac-
teria to the spleen was also greatly diminished, and the double
mutant appeared even more defective than the individual mu-
tants (Fig. 3B). By 48 h postinfection, the bacterial numbers in
the spleens of mice infected with the single mutants were
already 2 to 3 logs lower than those in wild-type-infected mice.
Deletion of both psaA and caf1 enhanced this dissemination
defect, as the psaA caf1 mutant strain was significantly more
attenuated than the wild-type strain (4 to 5 logs) and each
single mutant (2 to 3 logs). This dissemination defect was
also observed at 60 h postinfection, as the bacterial loads
recovered from the spleens of mice infected with the single and
double deletion strains were 2 logs and 4 logs lower, re-
spectively, than those recovered from wild-type-infected mice.
Taken together, these data suggest that, in addition to playing
a role in lung colonization in pneumonic plague, both PsaA
and F1 are required for efficient dissemination to the spleen.
To determine if the defects in tissue colonization of the
psaA, caf1, and psaA caf1 mutant strains during pneu-
monic infection result in a delay of death, a survival analysis
was performed. We infected C57BL/6J mice i.n. with 104 CFU
of the wild-type or the psaA, caf1, or psaA caf1 mutant
strain and monitored their progress every 12 h for 7 days
(Table 1). The MDD for the wild-type-infected mice was cal-
culated at 72 h postinfection. For the psaA and caf1 mutant
strains, the MDD was 84 h, a significant increase of 12 h over
the wild-type-infected mice (P 	 0.0013 and (P 
 0.0001,
respectively). An even greater delay of 24 h was determined for
the MDD of the psaA caf1 mutant-infected mice (MDD 	
96 h); this is a significant increase over that observed in the
wild-type or psaA mutant strain-infected mice (P 
 0.0001
and P 	 0.0096, respectively).
To verify that the phenotypes for the caf1 mutant strain are
due to the deletion of caf1 and not to a secondary mutation, we
restored caf1 to its original position, resulting in strain YP306.
This strain was tested in the same survival experiment de-
scribed above and displayed an MDD time frame similar to
that of the wild type (72 h), but due the fact that a few mice
infected with the complemented strain survived longer than
the wild-type-infected mice, a small but significant difference
was still present (P 	 0.0446). However, a significant restora-
tion of the caf1 mutant phenotype was observed (P 	 0.029),
indicating that the phenotype in the caf1 mutant is due the
deletion of caf1 and not a secondary mutation (Table 1). These
data are consistent with the colonization and dissemination
data.
The caf1 mutant strain is attenuated to a lesser degree in
bubonic plague in BALB/cJ mice than in C57BL/6J mice. In
contrast to recent reports suggesting that deletion of caf1 does
not dramatically affect the virulence of Y. pestis during pneu-
monic infection (10, 32, 36), our data indicate that F1 is re-
quired during plague infection. However, closer inspection of
the data of Quenee et al. and Cornelius et al. suggests that
there is a difference in survival after s.c. infection (10, 32). One
possible explanation for the differences in the degrees of at-
tenuation observed with the caf1 mutant strains between
FIG. 3. Colonization by and dissemination of psaA, caf1, and
psaA caf1 mutant Y. pestis strains in C57BL/6J mice during pneu-
monic plague. Mice were infected i.n. with 104 CFU of the wild-type
(diamonds) or psaA (triangles), caf1 (squares), or psaA caf1
(circles) mutant strain. Mice were sacrificed at 12, 48, and 60 h postin-
fection, and colonization of the lungs (A) and spleen (B) was deter-
mined. Each symbol represents an individual animal. Black bars cor-
respond to the median number of CFU/g of tissue for each group. The
dashed line indicates the limit of detection. Asterisks in the table
indicate a significant difference between the median number of CFU/g
of tissue compared to either the wild-type or the psaA caf1 mutant
strain (*, P  0.05; **, P  0.01; ***, P  0.005; na, not applicable;
ns, not significant). The data are a combination of three independent
experiments. The numbers of tissue samples harvested for the wild-
type and psaA, caf1, and psaA caf1 mutant strains, respectively,
were 9, 4, 10, and 10 at 12 h; 19, 11, 19, and 19 at 48 h; and 9, 12, 12,
and 11 at 60 h.
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these reports and our data is that all of our experiments were
performed with C57BL/6J mice, whereas BALB/cAnNCrl mice
were used in some of the other studies. To determine if the
mouse background influences the ability of Y. pestis mutants to
cause disease, we infected BALB/cJ mice s.c. with the wild-type
or psaA, caf1, or psaA caf1 mutant strain using the same
conditions as described for the C57BL/6J experiments (Fig. 1).
The wild-type and psaA mutant strains displayed similar
abilities to colonize the lymph nodes and disseminate to the
spleen and lungs in BALB/cJ mice compared to those observed
in C57BL/6J mice (Fig. 4A). The psaA mutant strain was
recovered at significantly lower levels from the lymph nodes
throughout the course of infection and also showed a delay in
dissemination to the spleen in BALB/cJ mice similar to that in
C57BL/6J mice. The psaA mutant was not detected in spleens
at 48 h but was detected at 72 h at a level 2 logs lower than
that in wild-type-infected mice (Fig. 4B). The psaA mutant
strain also showed diminished dissemination to the lungs, as
only 63% of the psaA-infected mice had detectable bacteria
(Fig. 4C).
Unlike the psaA mutant, the caf1 mutant strain was recov-
ered at wild-type levels at 36 h postinfection from the lymph
nodes of BALB/cJ mice. The caf1 mutant strain did not show
any expansion of the number of CFU/g between 36 and 72 h,
and the median lymph node burden in the caf1 mutant strain-
infected mice was 1 to 2 logs lower than in the wild-type-
infected mice and similar to those of psaA-infected mice at
both 48 h and 72 h. The caf1 mutant strain was recovered at
the same levels as the wild-type strain from spleens at 48 h
postinfection, whereas the bacterial load was 3 logs lower at
72 h postinfection. The caf1 mutant strain appears to be
unable to disseminate to the lungs by 72 h postinfection, as we
were unable to recover any live bacteria from the BALB/cJ-
infected mice at that time.
The decrease in the colonization of the lymph nodes of
psaA caf1-infected mice at 36 h appears to be mainly due to
the loss of psaA, as equal numbers of CFU of both strains
were recovered at that time, leading to a bacterial load 2 logs
lighter than that in wild-type- and caf1 mutant-infected mice.
At 48 h, the psaA caf1 mutant was recovered from the
lymph nodes at a level slightly lower than that of either of the
single mutants but 3 logs lower than that in wild-type-in-
fected mice. At 72 h, the psaA caf1 mutant strain was re-
covered at levels equivalent to those of the single mutants but
2 logs lower than that of the wild-type strain. The ability of
the psaA caf1 mutant strain to disseminate to the spleen and
lungs in BALB/cJ mice seems to be severely impacted, as we
were unable to recover any live bacteria from the spleens or
lungs of the majority of the psaA caf1-infected BALB/cJ
mice. Taken together, these data show that PsaA and F1 also
contribute to pathogenicity in BALB/cJ mice, but F1 appears
to impact bubonic infection to a lesser degree in BALB/cJ
mice.
DISCUSSION
Y. pestis is still a major threat to humans, due to endemic
pockets of Y. pestis-infected animals and fleas and potential
bioterrorism use. There is a need for a greater understanding
of the disease process, as well as the development of new
vaccine and molecular therapy candidates, and a greater un-
derstanding of the roles and functions of these candidates in Y.
pestis pathogenesis. One such candidate is the chaperone/usher
fimbria Psa, which recently was shown to provide incomplete
but significant protection against an attenuated Y. pestis strain
(20). The operon encoding this fimbria is expressed at the flea
vector temperature of 26°C, but a large increase in expression
is observed in the mammalian host and in vitro under mam-
malian host-like conditions such as a temperature shift and a
low pH (24, 30). This large increase in expression during the
mammalian phase of infection suggests an important role for
PsaA during infection. In vivo evidence supports this, as recent
work in our laboratory and others has shown that PsaA is
required during bubonic plague (3, 23).
Regardless of the route of infection, our data indicate that
psaA is required for the full pathogenicity of Y. pestis, inde-
pendent of the mouse background. The kinetic analyses of the
psaA mutant strain by either i.n. or s.c. infection revealed that
deletion of psaA leads to a reduction in the ability of Y. pestis
to colonize the initial site of infection (lung/lymph node) and
disseminate to the spleen. This reduction in colonization and
dissemination translates into an increase in the LD50, as we
observed a 400-fold increase in the LD50 of the psaA mutant
strain by the s.c. route over that of the wild-type strain.
These results for PsaA reaffirm our previously published
kinetic data (3) and also are in line with the LD50 of a strain
lacking RovA (3), a positive regulator of psaA (4). It further-
more is strengthened by data of an independent group which
observed a significant increase in the LD50 by the intravenous
route using psa mutants in the pgm mutant parental strain
TABLE 1. Analysis of Y. pestis wild-type and psaA, caf1, psaA caf1, and caf1 caf1 mutant strain survival in C57BL/6J mice during
pneumonic infection
Genotype
No. of surviving mice/total at postinfectiona time (h): Mean time
to death
(h)
Significant differenceb (P value) vs:
60 72 84 96 108 Wild type psaA mutant
Wild type 9/10 0/10 0/10 0/10 0/10 72 NAc 0.0013
psaA 10/10 7/10 1/10 0/10 0/10 84 0.0013 NA
caf1 10/10 10/10 5/10 0/10 0/10 84 
0.0001 0.0215
psaA caf1 10/10 10/10 6/10 1/10 0/10 96 
0.0001 0.0096
caf1 caf1 10/10 3/10 2/10 0/10 0/10 72 0.0446 NSd
a Mice were infected intranasally with 1  104 CFU.
b Statistical comparison of survival curves using the log rank test.
c NA, not applicable.
d NS, not significant.
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background (23). This finding stands in contrast to a recent
report indicating that PsaA is not required for virulence in
BALB/c mice (1). The difference in results is most likely not
due to the mouse background used, as we observed a similar
attenuation of the psaA mutant strain in both C57BL/6J mice
and BALB/cJ mice. One possible explanation for the disparity
in results could be the difference in the Y. pestis parent strains
used in the studies. A second possibility is that the wild-type
and mutant strains in the other study were animal passaged
several times before use in their experiments. This potentially
could select for isolates that have adapted to loss of the psa
locus by changes in their expression profile, leading to com-
pensation for the loss of PsaA and suppression of the attenu-
ation caused by the psaA mutation.
A second usher/chaperone fimbria that is a plague vaccine
and molecular therapy candidate is the Caf1 fimbria, also
known as the F1 antigen or capsule. Although the F1 antigen
has been shown to be required for successful transmission from
the flea to the mammalian host (36), contradicting observa-
tions have led to questions regarding its requirement in mam-
malian infection. The Java9 strain, a natural isolate from In-
donesian rats that lacks the caf locus, was determined to be
fully virulent in Swiss-Webster mice by the s.c. route but dis-
played attenuation in Hartley guinea pigs by the aerosol route
(16). These data, together with independent reports on other
mammalian hosts, indicate that at least some caf-negative
strains can be fully virulent in specific host backgrounds (10,
11, 17, 32, 36, 42, 45). However, this finding is counterbalanced
by the observation that the caf locus displays a strong upregu-
lation in the mammalian host, combined with the observation
that most natural isolates contain the caf locus (27, 44). These
observations, along with several reports indicating a require-
ment of the caf locus for full virulence, suggest a role for the F1
antigen during mammalian infection (2, 13, 17, 41, 43). How
can these various observations be reconciled? A starting point
is to test well-defined mutants under controlled experimental
conditions in inbred hosts.
Our data presented here show that F1 is required for Y.
pestis to achieve its full pathogenicity in both pneumonic and
bubonic plague in C57BL/6J mice. During pneumonic infec-
tion of mice, the caf1 mutant strain displayed a modest but
significant attenuation in the ability to colonize the lungs and a
greater decrease in the ability to disseminate to the spleen
compared to that of the wild-type strain. The kinetic analyses
of the caf1 mutant strain in the bubonic infection model
revealed that deletion of caf1 leads to a dramatic reduction in
FIG. 4. Colonization by and dissemination of psaA, caf1, and
psaA caf1 mutant strains of Y. pestis in BALB/cJ mice during bu-
bonic plague. Mice were infected s.c. in the neck with 102 CFU of the
wild-type (diamonds) or psaA (triangles), caf1 (squares), or psaA
caf1 (circles) mutant strain. Mice were sacrificed at 36, 48, and 72 h
postinfection, and colonization of the superficial cervical lymph nodes
(A), spleen (B), and lungs (C) was determined. Each symbol repre-
sents an individual animal. Black bars correspond to the median num-
ber of CFU/g of tissue for each group in BALB/cJ mice. Red bars
correspond to the median number of CFU/g of tissue for each group
in C57BL/6J mice (from Fig. 1). The dashed line indicates the limit of
detection. The symbol  indicates that a mouse was either euthanized
or found dead at that time point. An asterisk in a graph indicates a
significant difference in the median number of CFU/g of tissue be-
tween the psaA and caf1 mutant-infected groups, whereas asterisks
in the tables indicate significant differences in the median numbers of
CFU/g of tissue compared to either the wild-type or the psaA caf1
mutant strain (*, P  0.05; **, P  0.01; ***, P  0.005; na, not
applicable; ns, not significant). The data are a combination of three
independent experiments. The numbers of tissue samples harvested
for the wild-type and psaA, caf1, and psaA caf1 mutant strains,
respectively, were 8, 8, 7, and 8 at 36 h; 11, 12, 16, and 16 at 48 h; and
11, 8, 15, and 15 at 72 h.
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the ability of Y. pestis to colonize the lymph node and dissem-
inate to the spleen and lung. In fact, in this model, the caf1
mutant strain was more attenuated than the psaA mutant
strain, as the LD50 of the caf1 mutant strain is more than
100,000-fold greater than that of the wild type, which is signif-
icantly greater than the LD50 of the psaA mutant strain.
Evidence from in vitro studies suggests that Psa and F1 likely
have both overlapping and distinct functions (19, 25). Both
have been shown to have antiphagocytic properties, and PsaA
also has been shown to function as an adhesin for cells in
culture (14, 15, 18, 22). Thus, we investigated the potential
redundancy of these two fimbriae in vivo and found that PsaA
and Caf1 are both required for full pathogenicity in pneumonic
plague of C57BL/6J mice, as both single deletion strains dis-
played a modest but significant attenuation of the ability to
colonize the lungs and a decrease in the ability to disseminate
to the spleen. Moreover, Y. pestis lacking both fimbriae is more
attenuated than either of the single mutants for both coloni-
zation of the lungs and dissemination to (or survival in) the
spleen, and it is more attenuated in the pneumonic mouse
model in terms of mouse survival than either of the single
mutants.
Similar results were observed for the psaA caf1 mutant in
the bubonic model of infection of C57BL/6J mice. Deletion of
both fimbriae leads to a greater reduction in the ability of Y.
pestis to colonize the lymph node and disseminate to the spleen
and lungs compared to either single mutant. Analogous to the
caf1 mutant strain, we were unable to calculate an exact LD50
of the psaA caf1 mutant strain but could extrapolate from
the data that its LD50 was more than 100,000-fold greater than
that of the wild type. These data suggest that Caf1 and PsaA
are both required for Y. pestis pathogenesis in C57BL/6J mice
and are both required regardless of the route of infection.
The requirement for Caf1 in both pneumonic and bubonic
plague infections in our experiments at first appeared to be in
conflict with reports that suggest that the F1 antigen is not
required for virulence (10, 11, 17, 32, 36, 42, 45). However,
while no change in LD50 was observed by Quenee et al. and
Cornelius et al. during pneumonic infection, their data from a
bubonic infection indicated a change in the time to death (10,
32). The most notable difference between our data and these
reports was the background of mice used in the studies; BALB/
cAnNCrl mice were used by Quenee et al. (32) and Cornelius
et al. (10), whereas we used C57BL/6J mice. Thus, we tested
the wild-type strain and the caf1 mutant in BALB/cJ mice
and compared this to infection of C57BL/6J mice. Indeed, we
found that the wild type behaved similarly in the two strains of
mice but that the caf1 mutant was more attenuated in
C57BL/6J mice than in BALB/cJ mice. Our data support pre-
vious studies using the BALB/cAnNCrl mouse background in
which the caf1 mutant had no increase in LD50 but did show
a significant increase in MDD (10, 32). Though it was not to
the same degree as in C57BL/6J mice, we observed some
attenuation of our caf1 mutant strain in lymph node coloni-
zation and dissemination to the deeper tissues in BALB/cJ
mice in the s.c. kinetic experiments, which would explain the
delay in death in the previous studies (10, 32). These results
may shed light on the contradictory reports on the role of F1 in
the mammalian phase of infection of Y. pestis, as these data
indicate that the level of contribution of F1 is dependent on the
host genetic background. The fact that we observed different
degrees of attenuation in the two different mouse backgrounds
when using the same caf1 mutant strain could explain the
differences observed in previous reports for caf1 deletion
strains, as those reports used different mouse backgrounds.
Furthermore, our findings may also help explain differences in
F1 requirements for infections in different species, as the de-
gree of F1 requirement could be both intra- and interspecies
dependent.
The precise mechanism of attenuation of the caf1 mutant
strain and the functional role of the F1 antigen in the mam-
malian host are unclear; however, in vitro evidence suggests
that the F1 antigen plays a role in preventing phagocytosis
(14). The interplay of Caf1 with the innate immune systems of
genetically distinct mice could result in a different outcome for
the caf1 mutant strain. One of the known differences between
C57BL/6J and BALB/cJ mice is that C57BL/6J mice display a
Th1 cytokine profile whereas BALB/cJ mice display a Th2
cytokine profile. This difference is also reflected in their mac-
rophage activation state. C57BL/6J mice have M1 macro-
phages, which are more readily activated than the M2 macro-
phages found in BALB/cJ mice. One could postulate that if
Caf1 is required to resist macrophage activation, then Caf1
would be more important for infection of mice with M1 mac-
rophages (C57Bl/6J) than of mice with M2 macrophages
(BALB/cJ mice) that are activated less readily.
This work presents the first comprehensive analysis of both
wild-type and mutant Y. pestis strains in two different mouse
backgrounds and highlights the importance of the mouse back-
grounds used in the analysis of virulence factors of Y. pestis. We
observed no overt differences in wild-type Y. pestis s.c. infection
between the two mouse backgrounds, and our results with
BALB/cJ mice are similar to those of other groups using
BALB/cAnNCrl mice with wild-type Y. pestis (10, 32). This is in
contrast to a report that BALB/cJ mice are highly resistant to
Y. pestis, compared to C57BL/6J mice (38). Given the obser-
vations presented here that there is a differential effect in these
mouse backgrounds with various mutants but not with the wild
type, the most likely explanation for these differences is that in
that study an attenuated strain of Y. pestis (pgm mutant) was
used, whereas in our and other studies (10, 32) a fully virulent
strain was utilized. The wild-type fully virulent strain most
likely is able to overcome the difference between these mouse
backgrounds, as the disease progression is so rapid and acute.
In contrast, in infection with attenuated strains, disease pro-
gression is slower, potentially allowing subtle differences be-
tween mouse backgrounds to become apparent. Given the
observation that Y. pestis is able to withstand the innate im-
mune response of the host, by using numerous virulence fac-
tors to downplay this response or skew this response in its own
favor, it is perhaps not surprising that the analysis and inter-
pretation of the role of these potential virulence factors of Y.
pestis are influenced by the host genetic background. Our re-
sults suggest that caution should be used when drawing con-
clusions about infections of a single mouse background with
mutant strains of Y. pestis.
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